ImmunoTargets and Therapy is a leading open access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of immunology and its various therapeutic applications. Since its inception in 2012, the journal has rapidly become a vital resource for researchers, professionals, and students, achieving notable recognition with a Q1 ranking in both Immunology and Immunology and Allergy categories as of 2023. With an impressive Scopus ranking of #22 out of 233 in Medicine - Immunology and Allergy, and #25 out of 236 in Immunology and Microbiology, this journal maintains a 90th percentile standing in its field. ImmunoTargets and Therapy not only publishes original research articles, reviews, and clinical studies, but also fosters an inclusive platform for the dissemination of innovative findings critical to the fight against immunological disorders. Based in New Zealand, it serves a global audience, promoting knowledge exchange and collaboration through its open access model.

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.

LUPUS is a premier peer-reviewed journal published by SAGE Publications Ltd, focusing on the field of rheumatology, with a specific emphasis on the complexities of lupus and related autoimmune disorders. Since its inception in 1991, the journal has consistently ranked in the Q2 category within the rheumatology field, currently positioned as #29 out of 73 in Scopus, reflecting its significant contributions to research and clinical practice. The journal aims to foster a deeper understanding of lupus through the publication of original research articles, reviews, and clinical studies, making it an essential resource for researchers, clinicians, and students dedicated to advancing knowledge in this vital area of medicine. With an impact factor that underscores its influence, LUPUS serves as a critical platform for sharing innovative findings and engaging discussions within the global scientific community. Although the journal follows a traditional access model, it is situated in the United Kingdom, at 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, and remains dedicated to supporting the continuous advancement of research in autoimmune diseases.

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Therapeutic Advances in Musculoskeletal Disease is a premier, peer-reviewed journal published by SAGE Publications Ltd, focusing on the latest advancements in the understanding and treatment of musculoskeletal disorders. Since becoming an Open Access journal in 2019, it has significantly broadened its reach, providing researchers, clinicians, and practitioners with unfettered access to high-quality studies and reviews from 2009 to 2024. With an impressive impact factor reflected by its Q1 rank in Orthopedics and Sports Medicine and Q2 rank in Rheumatology for 2023, the journal occupies a critical position within its field. Ranked #31 out of 321 in Orthopedics and Sports Medicine and #17 out of 73 in Rheumatology on Scopus, it emphasizes both the clinical and scientific aspects of musculoskeletal health. This journal serves as a vital resource for advancing knowledge, encouraging collaboration, and fostering innovative treatment methods within the musculoskeletal community.

JOINT BONE SPINE is a premier peer-reviewed journal dedicated to advancing knowledge in the fields of rheumatology and orthopedics. Published by Elsevier France-Editions Scientifiques Medicales Elsevier, this esteemed journal has established itself as a key resource within the academic community, being categorized in the Q2 quartile of rheumatology journals for 2023. With an impressive impact as denoted by its Scopus rank of #26 out of 73, and a noteworthy 65th percentile, JOINT BONE SPINE serves as a vital platform for innovative research and clinical findings that address bone and joint diseases. The journal promotes open access, which enhances the dissemination of research findings, ensuring that practitioners, researchers, and students alike can easily access the latest developments and methodologies in the field. With a commitment to bridging scientific advances from 2000 to the present and beyond, JOINT BONE SPINE plays a critical role in shaping the future of musculoskeletal medicine and improving patient outcomes worldwide.

The International Journal of Rheumatology, published by HINDAWI LTD, serves as a vital resource for researchers and practitioners in the fields of rheumatology and immunology. Since its inception in 2009 as an Open Access journal, it has aimed to disseminate high-quality, peer-reviewed research to foster advancements in the understanding and treatment of rheumatic diseases. With an ISSN of 1687-9260 and E-ISSN of 1687-9279, the journal has become increasingly relevant, achieving a respectable Q3 ranking in both the Immunology and Rheumatology categories in 2023, and earning a Scopus rank of #27 out of 73 in Medicine Rheumatology. The journal's commitment to excellence is reflected in its wide-ranging scope, addressing current trends and innovations through empirical studies, reviews, and clinical insights. Its global readership, based in the United States and beyond, highlights the journal's importance in shaping the discourse within rheumatological research. As it converges through the years from 2010 to 2024, the International Journal of Rheumatology continues to be a cornerstone for sharing groundbreaking findings and fostering collaboration in the rheumatic disease community.

Current Opinion in Rheumatology, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of rheumatology. Since its inception in 1989, this prestigious journal has been at the forefront of disseminating cutting-edge research, with a notable Q1 ranking in the 2023 Rheumatology category and an impressive Scopus rank of 7 out of 73, placing it in the 91st percentile. The journal's commitment to presenting insightful reviews and critical analyses of recent advancements and treatment strategies makes it an essential read for professionals, researchers, and students dedicated to the study of rheumatic diseases. Although not an open-access journal, Current Opinion in Rheumatology continues to foster an informed dialogue within the academic community through its high-impact content, ensuring that the latest developments and practices are accessible to those at the vanguard of rheumatology research.

Immunity is a premier journal published by CELL PRESS that has positioned itself at the forefront of immunological research since its inception in 1994. With its ISSN 1074-7613 and E-ISSN 1097-4180, this prestigious journal is recognized for its significant contribution to the fields of Immunology, Allergy, and Infectious Diseases, consistently achieving a Q1 ranking in these categories as per 2023 metrics. The journal is highly esteemed within the academic community, holding impressive Scopus rankings—4th out of 344 in Infectious Diseases and 3rd in both Immunology and Immunology and Allergy—placing it in the 98th percentile. Although not an Open Access journal, it provides critical insights and research developments that empower researchers, healthcare professionals, and students alike. With a commitment to advancing scientific knowledge, Immunity is crucial for those interested in understanding immune responses and their implications for health and disease.